BK Medical E14CL4b Biplane Endocavity transducer Transrectal and Transvaginal probes
ID: 25-001380Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/feeff130c7d74a85bd8c6f52c81941e3/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm-fixed-price contract to BK Medical Holding Company, Inc. for the procurement of two E14CL4b Biplane Endocavity Transrectal and Transvaginal probes. These specialized probes are essential for supporting prostate biopsy fusion procedures, offering enhanced image quality and improved usability to facilitate efficient clinical operations, particularly in managing turnover times between surgical cases. The acquisition is being conducted under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole-source procurement due to the unique capabilities of the manufacturer. Interested parties may submit their capability statements to Damien Goines at damien.goines@nih.gov by November 20, 2024, at 6:30 AM EST.

    Point(s) of Contact
    Damien Goines
    (301) 827-4889
    damien.goines@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Inverted Routine Microscope System and Prime Life Science sCMOS Camera
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured Inverted Routine Microscope Systems and Prime Life Science sCMOS Cameras. This Sources Sought notice aims to gather details regarding the availability and capability of U.S. manufactured products that meet specific technical specifications, including advanced imaging capabilities and various illumination options. The procurement is crucial for supporting the NIH's oversight of foreign grant recipients and enhancing their administrative operations. Interested vendors must submit their capability statements by 11:59 AM Eastern Time on January 10, 2025, to the NIAID electronic Simplified Acquisition Submission System (eSASS), with all submissions being treated confidentially. For further inquiries, vendors can contact Rubyanne Matthews at rubyanne.matthews@nih.gov.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Service for Zeiss Confocal and Epifluorescence Microscopes
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), intends to procure preventative maintenance and emergency services for fourteen government-owned Zeiss microscopes, which are critical for cancer research conducted by the Laboratory of Cancer Biology and Genetics. The procurement will be conducted on a sole-source basis with Carl Zeiss Microscopy, LLC, the original equipment manufacturer, due to its proprietary software and the necessity for authorized service technicians to ensure compliance with manufacturer specifications. This maintenance contract is vital for maintaining the operational functionality of the microscopes, which play a significant role in biological specimen analysis. Interested parties, particularly small businesses, are invited to submit capability statements by January 6, 2025, to be considered for potential competitive procurement. For further inquiries, contact Lena Lee at lena.lee@nih.gov.
    Preventative Maintenance and Service Package for the Mediso nanoScan PET/CT animal imager
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking qualified vendors to provide a Preventative Maintenance and Service Package for the Mediso NanoScan PET/CT animal imager. This procurement involves a comprehensive service plan that includes a 12-month base period followed by four optional 12-month periods, commencing on February 10, 2025, at the Biomedical Research Center in Baltimore, Maryland. The Mediso NanoScan PET/CT is crucial for advanced imaging in biomedical research, and the selected vendor must demonstrate technical capabilities, customer support, and delivery speed as part of the evaluation process. Interested parties should note that the Request for Quotation (RFQ) number is 75N95025Q00104, with responses due by January 6, 2025. For further inquiries, vendors can contact Andrew Varley at andrew.varley@nih.gov or Joshua T. Lazarus at Josh.Lazarus@nih.gov.
    Q522--UroNav Fusion Biopsy Technician Services Lebanon VA Medical Center
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 4, intends to award a sole source contract for UroNav Fusion Biopsy Technician Services at the Lebanon VA Medical Center. This contract, which will be awarded to Fortec Medical, Inc. for a duration of five years, aims to provide certified technicians to support approximately 180 prostate fusion biopsy procedures annually, ensuring 24/7 availability for both scheduled and emergency cases. The services are critical for enhancing healthcare delivery to veterans, as the UroNav Fusion Biopsy System is specialized equipment that requires authorized servicing. Interested vendors must submit a capability statement by January 7, 2024, to the Contract Specialist, Eleanor Robbins, at eleanor.robbins@va.gov, as this procurement falls under NAICS code 541990 and is governed by FAR 13.5 and 41 USC 253(c)(1).
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Notice of Intent to Sole Source – TheraDoc subscription
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    NIH-NIAID docuBridge Upgrade
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to award a sole source contract for the upgrade of the LORENZ docuBridge system from version 21.1 to version 24.2. This upgrade is crucial for maintaining regulatory compliance, adhering to industry standards, and minimizing security vulnerabilities associated with the NIAID Electronic Common Technical Document (eCTD) system, which was initially implemented using commercial off-the-shelf software from LORENZ International, LLC. The contract will include services such as system configuration, role-based training for staff, and maintaining compliance with 21 CFR Part 11 regulations, with an estimated performance period from January 20, 2025, to September 29, 2025. Interested vendors may submit their capabilities statements to Tamara McDermott at tamara.mcdermott@nih.gov within 18 days of this notice, although the government plans to proceed with a sole source award within 25 days.